Although the upregulation of CD248 was associated with tumor angiogenesis and metastasis [59], the upregulation of CD248 in the dry fasted serum at the end of 4-week DDDF is likely due to physiological angiogenesis rather than pathological tumor angiogenesis observed in several cancers. Here, CD248 is linked to cancer.